Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Recombination can drive tumourogenesis
Prof James Haber - Brandeis University, Waltham, USA
Recombination can drive tumourogenesis ( Prof James Haber - Brandeis University, Waltham, USA )
29 Jan 2016
The role of the PI3K and TOR pathways in cancer
Dr David Fruman - University of California, Irvine, USA
The role of the PI3K and TOR pathways in cancer ( Dr David Fruman - University of California, Irvine, USA )
29 Jan 2016
Utilising disease heterogeneity and emerging biomarkers to individualise...
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
22 Jan 2016
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC
Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC ( Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following...
Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer ( Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016
Molecular genetics of testicular cancer: What does the clinician need to know?
Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA
Molecular genetics of testicular cancer: What does the clinician need to know? ( Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer
Prof Eleni Efstathiou and Prof Nick James
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer ( Prof Eleni Efstathiou and Prof Nick James )
7 Jan 2016
Actionable targets in patients with cisplatin-resistant advanced germ cell...
Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours ( Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA )
7 Jan 2016
Global cancer partnership
Dr Lisa Stevens - National Cancer Institute, Washington, USA
Global cancer partnership ( Dr Lisa Stevens - National Cancer Institute, Washington, USA )
17 Dec 2015
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response...
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
ER and FGFR1 interaction critical in endocrine resistant breast cancer
Dr Luigi Formisano - Vanderbilt University Nashville, USA
ER and FGFR1 interaction critical in endocrine resistant breast cancer ( Dr Luigi Formisano - Vanderbilt University Nashville, USA )
16 Dec 2015
Interrupting breast cancer treatment for young women who desire pregnancy
Dr Olivia Pagani and Dr Ann Partridge
Interrupting breast cancer treatment for young women who desire pregnancy ( Dr Olivia Pagani and Dr Ann Partridge )
16 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation